| Lithuania | Turkey | Austria | |
| Total knee replacement (arthroplasty) revision | - | from $6,889 | - |
| Total hip replacement (arthroplasty) revision | - | from $12,000 | - |
| Stem cell therapy for knees | - | from $2,700 | - |
| Stem cell therapy for arthritis | - | from $2,750 | - |
| Stem Cell Therapy | - | from $4,018 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Injuries of bones and joints treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Injuries of bones and joints treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Injuries of bones and joints treatment journey.
Meliva Kardiolita Hospital is a private multi-specialty medical center in Vilnius, Lithuania. The hospital specializes in orthopedics, cardiac surgery, plastic surgery, and weight loss procedures. It treats only adult patients and welcomes around 298,000 individuals annually. Most international patients come from the CIS, Europe, the Commonwealth, the USA, Canada, and Australia.
The Medical Diagnostic and Treatment Center is one of the largest private clinics in Lithuania. Specialists focus on accurate diagnostics for more effective treatment. They also develop high-quality rehabilitation for fast recovery. Over 48,000 patients undergo treatment in the Hospital. 1 in 10 patients is from abroad. The most of patients are from the United Kingdom, Ireland, Sweden, and Norway.
A 1978 graduate of Kaunas Medical Institute with internships in Austria, Germany, USA, etc. Author of more than 50 scientific publications, and a member of several organizations including the Vice President of Lithuania Orthopaedists-Traumatolologists Society, the European Orthopaedists-Traumatologists Federation and the General Assembly, the Lithuanian Society of Paediatric, and the Board of Experimental and Clinical Medicine Institute, Vilnius University.